GSTM1 and thalassemia: Of the patients, 238 (82.6%) had homozygous β-thalassaemia major, 47 (16.4%) had haemoglobin (Hb) E β-thalassaemia and three (1.0%) patients had other forms of transfusion dependent β-thalassaemia.